共 22 条
[5]
Bichsel VE, 2001, CANCER J, V7, P69
[8]
Considerations in the evaluation of surrogate endpoints in clinical trials: Summary of a National Institutes of Health Workshop
[J].
CONTROLLED CLINICAL TRIALS,
2001, 22 (05)
:485-502